These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35721017)

  • 1. Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment.
    Laczó M; Martinkovic L; Lerch O; Wiener JM; Kalinova J; Matuskova V; Nedelska Z; Vyhnalek M; Hort J; Laczó J
    Front Aging Neurosci; 2022; 14():886778. PubMed ID: 35721017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial Pattern Separation Testing Differentiates Alzheimer's Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment.
    Laczó M; Lerch O; Martinkovic L; Kalinova J; Markova H; Vyhnalek M; Hort J; Laczó J
    Front Aging Neurosci; 2021; 13():774600. PubMed ID: 34899277
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.
    Wu L; Arvai S; Wang SJ; Liu AJ; Xu B
    Front Mol Neurosci; 2023; 16():1288930. PubMed ID: 38260807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Alzheimer's disease on spatial navigation strategies.
    Parizkova M; Lerch O; Moffat SD; Andel R; Mazancova AF; Nedelska Z; Vyhnalek M; Hort J; Laczó J
    Neurobiol Aging; 2018 Apr; 64():107-115. PubMed ID: 29358117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-space navigation testing differentiates between amyloid-positive and -negative aMCI.
    Schöberl F; Pradhan C; Irving S; Buerger K; Xiong G; Kugler G; Kohlbecher S; Engmann J; Werner P; Brendel M; Schneider E; Perneczky R; Jahn K; la Fougère C; Bartenstein P; Brandt T; Dieterich M; Zwergal A
    Neurology; 2020 Feb; 94(8):e861-e873. PubMed ID: 31896617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial Navigation and Visuospatial Strategies in Typical and Atypical Aging.
    Laczó M; Wiener JM; Kalinova J; Matuskova V; Vyhnalek M; Hort J; Laczó J
    Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial navigation and APOE in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vlček K; Macoška V; Vyhnálek M; Tolar M; Bojar M; Hort J
    Neurodegener Dis; 2011; 8(4):169-77. PubMed ID: 21124005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial navigation questionnaires as a supportive diagnostic tool in early Alzheimer's disease.
    Laczó M; Svatkova R; Lerch O; Martinkovic L; Zuntychova T; Nedelska Z; Horakova H; Vyhnalek M; Hort J; Laczó J
    iScience; 2024 Jun; 27(6):109832. PubMed ID: 38779476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.
    Li K; Qu H; Ma M; Xia C; Cai M; Han F; Zhang Q; Gu X; Ma Q
    Front Aging Neurosci; 2022; 14():816043. PubMed ID: 35547625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
    Laczó J; Cechova K; Parizkova M; Lerch O; Andel R; Matoska V; Kaplan V; Matuskova V; Nedelska Z; Vyhnalek M; Hort J
    J Alzheimers Dis; 2020; 78(4):1473-1492. PubMed ID: 33325388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing mild cognitive impairment using object-location memory in immersive virtual environments.
    Castegnaro A; Howett D; Li A; Harding E; Chan D; Burgess N; King J
    Hippocampus; 2022 Sep; 32(9):660-678. PubMed ID: 35916343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairment.
    Yi D; Choe YM; Byun MS; Sohn BK; Seo EH; Han J; Park J; Woo JI; Lee DY
    Front Aging Neurosci; 2015; 7():15. PubMed ID: 25745400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation.
    Howett D; Castegnaro A; Krzywicka K; Hagman J; Marchment D; Henson R; Rio M; King JA; Burgess N; Chan D
    Brain; 2019 Jun; 142(6):1751-1766. PubMed ID: 31121601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects.
    Duara R; Loewenstein DA; Shen Q; Barker W; Varon D; Greig MT; Curiel R; Agron J; Santos I; Potter H
    Front Aging Neurosci; 2013; 5():47. PubMed ID: 24065917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the contribution of spatial navigation to cognitive functioning in older adults.
    Laczó J; Andel R; Nedelska Z; Vyhnalek M; Vlcek K; Crutch S; Harrison J; Hort J
    Neurobiol Aging; 2017 Mar; 51():67-70. PubMed ID: 28039765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of Normative Volumetric Estimates from Open Access Software in Amnestic Mild Cognitive Impairment.
    Fountain-Zaragoza S; Horn O; Thorn KE; Kraal AZ; Benitez A
    J Prev Alzheimers Dis; 2023; 10(2):236-243. PubMed ID: 36946450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial Pattern Separation in Early Alzheimer's Disease.
    Parizkova M; Lerch O; Andel R; Kalinova J; Markova H; Vyhnalek M; Hort J; Laczó J
    J Alzheimers Dis; 2020; 76(1):121-138. PubMed ID: 32444544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.